In continuation of its earlier letter dated 24th October, 2019, regarding the admission of petition by the National Company Law Tribunal (NCLT), Mumbai Bench, in order dated 22.10.2019 the certified copy of which was received by the Company on 23.10.2019, filed by one of the Operational Creditors, Scorpion Express (Scorpion), Gufic Biosciences has informed that the company and Scorpion have reached a settlement. The agreement of settlement has been signed on 25.10.2019 between both the parties and accordingly Scorpion will file an application for withdrawal of the petition before the NCLT. As the NCLT is on vacation, the said application for withdrawal shall be made after NCLT will resume, on or after 04.11.2019.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: